Pressmeddelande

Annual Report 2023

Surgical Science has today published its Annual Report for 2023. The document is attached to this press release and is also available at www.surgicalscience.com. Printed copies are sent to the shareholder who so requests and states his/her postal address.

Gothenburg, Sweden, April 18, 2024
Surgical Science Sweden AB (publ)

The Annual Report is available in the attachment or via
https://surgicalscience.com/investor-relations/#press-releases
https://surgicalscience.com/investor-relations/#financial-report

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 260 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Tel Aviv, Israel, as well as in Stockholm, Sweden and in Seattle and Cleveland, US. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is Carnegie Investment Bank AB (publ).

Source:MFN

Tillbaka

Det verkar som att du använder en annonsblockerare

Logga in på di.se

Inte prenumerant än?

Tillgång till alla nyhetsbrev med en prenumeration